Results 41 to 50 of about 183 (136)
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. [PDF]
J Transl Med, 2021 Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C, TOCIVID-19 investigators, Italy. +37 moreeuropepmc +1 more sourceUse of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients. [PDF]
Clin Interv Aging, 2021 Franchi C, Lancellotti G, Bertolotti M, Di Salvatore S, Nobili A, Mannucci PM, Mussi C, Ardoino I, REPOSI (REgistro POliterapie SIMI, Società Italiana di Medicina Interna) Study Group. +9 moreeuropepmc +1 more sourceEarly experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. [PDF]
Euro Surveill, 2020 Lagi F, Piccica M, Graziani L, Vellere I, Botta A, Tilli M, Ottino L, Borchi B, Pozzi M, Bartalesi F, Mencarini J, Spinicci M, Zammarchi L, Pieralli F, Zagli G, Nozzoli C, Romagnoli S, Bartoloni A, COCORA working group, COCORA working group members not listed as individual author. +19 moreeuropepmc +1 more sourceBeta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register. [PDF]
Front Cardiovasc Med, 2022 Arcoraci V, Squadrito F, Rottura M, Barbieri MA, Pallio G, Irrera N, Nobili A, Natoli G, Argano C, Squadrito G, Corrao S. +10 moreeuropepmc +1 more sourceTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. [PDF]
J Transl Med, 2020 Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C, TOCIVID-19 investigators, Italy. +37 moreeuropepmc +1 more sourceComparability of Liquid Chromatography Tandem Mass Spectrometry Analysis of Dissolved Organic Matter across Laboratories. [PDF]
Environ Sci TechnolKalinski JC, Ruiz Brandão da Costa B, Schramm T, Buckett LR, Carlson LT, Coffey NR, Damiani T, Dechent E, Abiead YE, Heuckeroth S, Jennings EK, Kaesler J, Stock NL, Orme AM, Torres RR, Trojahn S, Whelton HL, Yan Y, Aron AT, Boiteau RM, Bull ID, Dorrestein PC, Dang DH, Evershed RP, Gledhill M, Gleixner G, Haas AF, Hansen M, Harder T, Hopmans EC, Ingalls AE, Karst U, Kew W, Kido Soule M, Koch BP, Kujawinski EB, Lechtenfeld OJ, Longnecker K, Pluskal T, Pohnert G, Redman ZC, Rivas-Ubach A, Schmitt-Kopplin P, Singer G, Tebben J, Tomco PL, Ward ND, Aluwihare LI, Simon C, Hawkes J, Petras D. +50 moreeuropepmc +1 more sourceCorrection to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies. [PDF]
Rheumatol IntKadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, Andreoli L, Parodis I, Tan AL, Shinjo SK, Dey D, Cavagna L, Chatterjee T, Knitza J, Wang G, Dalbeth N, Velikova T, Battista S, Cheng K, Boyd P, Kobert L, Gracia-Ramos AE, Mittal S, Makol A, Gutiérrez CET, Caballero-Uribe CV, Kuwana M, Burmester GR, Guillemin F, Nikiphorou E, Chinoy H, COVAD Study group, Agarwal V, Agarwal V, Gupta L. +35 moreeuropepmc +1 more source
